DiscoverWall Street BreakfastBristol-Myers wins FDA nod for novel antipsychotic
Bristol-Myers wins FDA nod for novel antipsychotic

Bristol-Myers wins FDA nod for novel antipsychotic

Update: 2024-09-271
Share

Description

Bristol-Myers (BMY) wins FDA nod for first-of-its-kind antipsychotic. (00:25 ) DirecTV, Dish (SATS) close in on merger to form largest US pay-TV service: Bloomberg. (01:11 ) Major Trump Media (DJT) shareholder dumps nearly entire stake. (02:18 )

Episode transcripts seekingalpha.com/wsb.

Show links: 
Hurricane Helene misses 'most prolific' Gulf of Mexico oil and gas producing areas
U.S. and Intel could close $8.5B chip funding by year-end - report
Intel said to rebuff approach by Arm Holdings for product unit

Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Bristol-Myers wins FDA nod for novel antipsychotic

Bristol-Myers wins FDA nod for novel antipsychotic

Seeking Alpha